Dr. Miriam Robota is Head of Formulation Services within Evonik Operations GmbH in Darmstadt. In this function, she is responsible for the business development and implementation of formulation development service projects with focus on pharmaceutical solid oral dosage forms. In her function, she is further giving technical consultation and trainings on the Evonik Health Care product portfolio.
She received her degree in Pharmacy in 2009 at the Johann Wolfgang Goethe University Frankfurt, Germany. After an internship at Merck Selbstmedikation GmbH in Darmstadt, Germany in the quality control of solid dosage forms, Dr. Robota completed her Ph.D. studies in Pharmaceutical Technology in 2014 at the Johann Wolfgang Goethe University Frankfurt, Germany. The topic of her thesis was the development, characterization, and in vitro testing of biodegradable nanoparticle formulations for treatment of neurological diseases.
Following to her Ph.D. thesis, she started her industrial career in 2014 at Evonik as Manager Technical Service for Western Europe, followed by several functions within Evonik over the years, such as heading the Formulation Development Laboratory, Application Technology Laboratory and Production of clinical sample manufacturing for clinical studies phase I and II. During this time, Dr. Robota gained substantial knowledge in the application of EUDRAGIT
® within the formulation development of solid oral dosage forms with immediate and modified release.
Dr. Robota is regular speaker at workshops and international conferences and is author of several publications.